Flashcards in QUANTEC Deck (75):
1
brain lower max dose
< 60Gy
<3%
symptomatic necrosis
2
brain middle max dose
72Gy
5%
symptomatic necrosis
3
brain upper max dose
90Gy
10%
symptomatic necrosis
4
brain stem lower max dose
< 54Gy
<5%
neuropathy or necrosis
5
brain stem middle tolerance dose
dose to 1-10cc 5%
neuropathy or necrosis
6
brain stem upper max dose
< 64Gy to point dose << 1cc
<5%
neuropathy or necrosis
7
optic nerve/chiasm lower max dose
55Gy
tox<3%
optic neuropathy
8
optic nerve/chiasm middle max dose
55-60Gy
3-7%
optic neuropathy
9
optic nerve/chiasm upper max dose
>60Gy
>7-20%
optic neuropathy
10
spinal cord lower max dose
50Gy
0.2%
myelopathy
11
spinal cord middle max dose
60Gy
6%
myelopathy
12
spinal cord higher max dose
69Gy
50%
myelopathy
13
cochlea mean dose
45Gy
tox<30%
sensory-neural hearing loss
14
cochlea mobius tolerance limit
V55 < 5%
15
parotid bilat lower mean dose
25Gy
tox <25%
16
parotid bilat upper mean dose
39Gy
tox <25%
17
parotid unilat mean dose
20Gy
tox <25%
18
pharyngeal constrictors mean dose
50Gy
tox<20%
symptomatic dysphagia & aspiration
19
larynx max dose
66Gy
tox<20%
vocal dysfxn
20
larynx upper mean dose
50Gy
<30%
aspiration
21
larynx lower mean dose
44Gy
tox <20%
edema
22
larynx volume dose
V50 < 27%
<20%
edema
23
lung volume dose
V20 less than 30%
tox<20%
symptomatic pneumonitis
24
lung 1st mean dose
7Gy
5%
symptomatic pneumonitis
25
lung 2nd mean dose
13Gy
10%
symptomatic pneumonitis
26
lung 3rd mean dose
20Gy
20%
symptomatic pneumonitis
27
lung 4th mean dose
24Gy
30%
symptomatic pneumonitis
28
lung 5th mean dose
27Gy
40%
symptomatic pneumonitis
29
esophagus mean dose
<34Gy
5-20%
grade 3+ esophagitis
30
esophagus lower volume dose
V35 < 50%
<30%
grade 2+ esophagitis
31
esophagus middle volume dose
V50 < 40%
<30%
grade 2+ esophagitis
32
esophagus upper volume dose
V70 < 20%
<30%
grade 2+ esophagitis
33
heart/pericardium mean dose
< 26Gy
<15%
pericarditis
34
heart/pericardium volume dose
V30 < 46%
<15%
pericarditis
35
heart volume dose
V25 < 10%
<1%
long term cardiac mortality
36
normal liver gtv lower mean dose
30-32Gy
tox<5%
RILD
37
normal liver gtv upper mean dose
42Gy
tox <50%
RILD
38
HCC/Child Pugh A liver gtv lower mean dose
28Gy
tox<5%
RILD
39
HCC/Child Pugh A liver gtv upper mean dose
36Gy
tox<50%
RILD
40
kidney bilat lower mean dose
15-18Gy
tox<5%
clinical dysfxn
41
kidney bilat upper mean dose
28Gy
tox<50%
clinical dysfxn
42
kidney bilat 1st volume dose
V12 < 55%
<5%
clinical dysfxn
43
kidney bilat 2nd volume dose
V20 < 32%
<5%
clinical dysfxn
44
kidney bilat 3rd volume dose
V23 < 30%
<5%
clinical dysfxn
45
kidney bilat 4th volume dose
V28 < 20%
<5%
clinical dysfxn
46
stomach volume dose
D100 < 45Gy
<7%
ulceration
47
small bowel individual loops volume dose
V15 < 120cc
<10%
grade 3+ toxicity
48
small bowel peritoneal cavity volume dose
V45 < 195cc
<10%
grade 3+ toxicity
49
rectum 1st volume dose
V50 < 50%
<10%
grade 3+ toxicity
50
rectum 2nd volume dose
V60 < 35%
<10%
grade 3+ toxicity
51
rectum 3rd volume dose
V65 < 25%
<10%
grade 3+ toxicity
52
rectum 4th volume dose
V70 < 20%
<10%
grade 3+ toxicity
53
rectum 5th volume dose
V75 < 15%
<10%
grade 3+ toxicity
54
bladder (bladder CA) max dose
65Gy
tox<6%
grade 3+ toxicity
55
bladder (prost CA) 1st volume dose
V65 < 50%
grade 3+ toxicity
56
bladder (prost CA) 2nd volume dose
V70 < 35%
grade 3+ toxicity
57
bladder (prost CA) 3rd volume dose
V75 < 25%
grade 3+ toxicity
58
bladder (prost CA) 4th volume dose
V80 < 15%
grade 3+ toxicity
59
brachial plexus mobius max dose
<66Gy
60
brachial plexus mobius volume dose
5% < 60Gy
61
fem heads mobius max dose
<50Gy
62
fem head mobius lower volume dose
25% < 45Gy
63
fem head mobius upper volume dose
40% < 40Gy
64
eyes mobius max dose
<50Gy
65
eyes mobius mean dose
< 35Gy
66
lens mobius max dose
< 25Gy
67
SRS brain volume dose
V12Gy < 5-10cc
<20%
symptomatic necrosis
68
SRS brain stem (acoustic tumors) max dose
< 12.5Gy
<5%
neuropathy or necrosis
69
SRS optic nerve/chiasm max dose
< 12Gy
<10%
optic neuropathy
70
SRS spinal cord max dose
13Gy
1%
myelopathy
71
SRS 3 fx spinal cord max dose
20Gy
1%
myelopathy
72
SRS cochlea volume dose
Rx dose sensory neural hearing loss
73
SRS 3 fx liver/HCC lower mean dose
13Gy
tox<5%
RILD
74
SRS 3 fx liver/mets upper mean dose
15Gy
tox<5%
RILD
75